Information2015
- Nov. 10, 2015 IR Regarding Judgment by the UK Court
- Nov. 6, 2015 IR Second Quarter Financial Results
- Nov. 6, 2015 IR Notice of Posting of Non-Operating Expenses (Foreign Currency Exchange Loss)
- Oct. 26, 2015 Corporate About Olympus Medical Business is now live
- Sep. 16, 2015 IR Announcing the Upcoming Release of a 4K Surgical Endoscopy System
- Sep. 1, 2015 IR Annual Report 2015
- Aug. 6, 2015 IR First Quarter Financial Results
- Aug. 6, 2015 IR Notice of Recognition of Extraordinary Loss Due to the Investigation by the U.S. Department of Justice Against Subsidiaries Relating to the Foreign Corrupt Practices Act
- Aug. 6, 2015 IR Announcement of the Overview of Evaluation Results for Effectiveness of Board of Directors
- Jul. 13, 2015 IR Notice Concerning the Final Details of the Issuance of Stock Options (Warrant) Remuneration Grant
- Jun. 26, 2015 IR Notice Concerning Stock Option (Warrant) Remuneration Grant (Notice concerning Decisions on Subscription Requirements)
- Jun. 26, 2015 IR Notice Regarding the Formulation of the "Basic Policy for Corporate Governance"
- Jun. 26, 2015 IR Notice Regarding Recording of Extraordinary Income (Income on Extinguishment of Tie-in Shares) and Extraordinary Loss (Loss on Extinguishment of Tie-in Shares) as a Result of Absorption-type Merger and Absorption-type Split of the Subsidiaries
- Jun. 15, 2015 IR Supplementary Explanations of the Agenda for the General Meeting of Shareholders For the 147th term
- Jun. 5, 2015 IR Olympus Medical Business posted
- Jun. 1, 2015 IR Notice of Early Disclosure regarding the Convocation of the General Meeting of Shareholders for the 147th Term
- May. 8, 2015 IR Financial Results
- May. 8, 2015 IR Recognition of Extraordinary Loss Due to the Investigation by the U.S. Department of Justice Against Our Subsidiary and Notice of Difference Between Consolidated Earnings Forecast and Actual Results
- May. 8, 2015 IR Notice Concerning Dividend of Surplus (Resumption of Dividend)
- May. 8, 2015 IR Notification with new appointment of the executive members
- May. 8, 2015 IR Renewal of Countermeasures to Large-Scale Acquisitions of Olympus Corporation Shares (Takeover Defense Measures)
- May. 7, 2015 Corporate Olympus Duodenoscope Statement
- Apr. 1, 2015 IR Notice Concerning Change in Largest Shareholder (Principal Shareholder)
- Mar. 27, 2015 IR Notice Concerning Settlements of Lawsuits for Damages
- Mar. 6, 2015 IR Notice Concerning Media Reports on Our Duodenoscope in the U.S.
- Feb. 6, 2015 IR Third Quarter Financial Results
- Feb. 6, 2015 IR Notice of Investigation by the U.S. Department of Justice against Our Subsidiary
- Jan. 22, 2015 IR Notice of Response to Vulnerability in SSL 3.0
- Jan. 13, 2015 Corporate Notice of Management Structure Reinforcement (Reorganization) to Realize Strategic Business Expansion